دورية أكاديمية

Development of L-Lysine-Loaded PLGA Microparticles as a Controlled Release System for Angiogenesis Enhancement

التفاصيل البيبلوغرافية
العنوان: Development of L-Lysine-Loaded PLGA Microparticles as a Controlled Release System for Angiogenesis Enhancement
المؤلفون: Gallo N., Quarta S., Massaro M., Carluccio M. A., Barca A., Cannoletta D., Siculella L., Salvatore L., Sannino A.
المساهمون: Gallo, N., Quarta, S., Massaro, M., Carluccio, M. A., Barca, A., Cannoletta, D., Siculella, L., Salvatore, L., Sannino, A.
سنة النشر: 2023
المجموعة: Università del Salento: CINECA IRIS
مصطلحات موضوعية: angiogenesi, drug delivery system, L-lysine, microsphere, PLGA
الوصف: Vascularization is a highly conserved and considerably complex and precise process that is finely driven by endogenous regulatory processes at the tissue and systemic levels. However, it can reveal itself to be slow and inadequate for tissue repair and regeneration consequent to severe lesions/damages. Several biomaterial-based strategies were developed to support and enhance vasculogenesis by supplying pro-angiogenic agents. Several approaches were adopted to develop effective drug delivery systems for the controlled release of a huge variety of compounds. In this work, a microparticulate system was chosen to be loaded with the essential amino acid L-lysine, a molecule that has recently gained interest due to its involvement in pro-angiogenic, pro-regenerative, and anti-inflammatory mechanisms. Poly (lactic-co-glycolic acid), the most widely used FDA-approved biodegradable synthetic polymer for the development of drug delivery systems, was chosen due to its versatility and ability to promote neovascularization and wound healing. This study dealt with the development and the effectiveness evaluation of a PLGA-based microparticulate system for the controlled release of L-lysine. Therefore, in order to maximize L-lysine encapsulation efficiency and tune its release kinetics, the microparticle synthesis protocol was optimized by varying some processing parameters. All developed formulations were characterized from a morphological and physicochemical point of view. The optimized formulation was further characterized via the evaluation of its preliminary biological efficacy in vitro. The cellular and molecular studies revealed that the L-lysine-loaded PLGA microparticles were non-toxic, biocompatible, and supported cell proliferation and angiogenesis well by stimulating the expression of pro-angiogenic genes such as metalloproteinase-9, focal adhesion kinases, and different growth factors. Thus, this work showed the potential of delivering L-lysine encapsulated in PLGA microparticles as a cost-effective promoter ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: ELETTRONICO
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000939977900001; volume:15; firstpage:479; journal:PHARMACEUTICS; https://hdl.handle.net/11587/488049Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85149134294; https://www.mdpi.com/1999-4923/15/2/479Test
DOI: 10.3390/pharmaceutics15020479
الإتاحة: https://doi.org/10.3390/pharmaceutics15020479Test
https://hdl.handle.net/11587/488049Test
https://www.mdpi.com/1999-4923/15/2/479Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.62899614
قاعدة البيانات: BASE